This inventor holds 1 USPTO granted patent. Top assignee: Michigan Biotechnology Institute. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Innovations of Chanyong Lee in Biotechnology
Introduction
Chanyong Lee is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of glucose isomerases. His work focuses on enhancing the efficiency of these enzymes, which play a crucial role in various industrial applications.
Latest Patents
Chanyong Lee holds a patent for "Glucose isomerases with improved affinity for D-glucose." This invention involves a genetically engineered glucose isomerase that exhibits an improved affinity for D-glucose. The method of preparation for this glucose isomerase includes mutagenizing the gene of a naturally occurring glucose isomerase, allowing a smaller amino acid to replace a larger amino acid in the catalytic site. In a particularly advantageous embodiment, the Clostridium glucose isomerase sequence is mutated, with the residue replaced by a smaller amino acid, either Trp.sub.139 or Val.sub.186. This innovation has the potential to enhance the efficiency of glucose conversion processes.
Career Highlights
Chanyong Lee is associated with the Michigan Biotechnology Institute, where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in biotechnology and industrial processes.
Collaborations
Chanyong collaborates with talented individuals such as Menghsiao Meng and Michael Bagdasarian. Their combined expertise contributes to the innovative projects at the Michigan Biotechnology Institute.
Conclusion
Chanyong Lee's contributions to biotechnology, particularly through his patented innovations, highlight the importance of research in improving industrial processes. His work exemplifies the potential of genetic engineering in enhancing enzyme efficiency.